175 related articles for article (PubMed ID: 15855729)
1. [Oxidative stress in diabetes].
Mizuta M
Nihon Yakurigaku Zasshi; 2005 Mar; 125(3):125-8. PubMed ID: 15855729
[No Abstract] [Full Text] [Related]
2. Recent progress in advanced glycation end products and diabetic complications.
Vlassara H
Diabetes; 1997 Sep; 46 Suppl 2():S19-25. PubMed ID: 9285494
[No Abstract] [Full Text] [Related]
3. [Role of oxidative stress in diabetic vascular complications].
Inoguchi T; Takayanagi R
Fukuoka Igaku Zasshi; 2008 Mar; 99(3):47-55. PubMed ID: 18536327
[No Abstract] [Full Text] [Related]
4. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis.
Lalla E; Lamster IB; Drury S; Fu C; Schmidt AM
Periodontol 2000; 2000 Jun; 23():50-62. PubMed ID: 11276765
[No Abstract] [Full Text] [Related]
6. Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus.
Lee J; Yun JS; Ko SH
Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956261
[TBL] [Abstract][Full Text] [Related]
7. Glycation as the glucose link to diabetic complications.
Gugliucci A
J Am Osteopath Assoc; 2000 Oct; 100(10):621-34. PubMed ID: 11105451
[TBL] [Abstract][Full Text] [Related]
8. Regulation of RAGE for attenuating progression of diabetic vascular complications.
Win MT; Yamamoto Y; Munesue S; Saito H; Han D; Motoyoshi S; Kamal T; Ohara T; Watanabe T; Yamamoto H
Exp Diabetes Res; 2012; 2012():894605. PubMed ID: 22110482
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis impairment by the NADPH oxidase-triggered oxidative stress at the bone-implant interface: Critical mechanisms and therapeutic targets for implant failure under hyperglycemic conditions in diabetes.
Hu XF; Wang L; Xiang G; Lei W; Feng YF
Acta Biomater; 2018 Jun; 73():470-487. PubMed ID: 29649637
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of diabetic nephropathy: a radical approach.
Salahudeen AK; Kanji V; Reckelhoff JF; Schmidt AM
Nephrol Dial Transplant; 1997 Apr; 12(4):664-8. PubMed ID: 9140991
[No Abstract] [Full Text] [Related]
11. Hyperglycemia and the pathobiology of diabetic complications.
Aronson D
Adv Cardiol; 2008; 45():1-16. PubMed ID: 18230953
[TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia Induces Toll-Like Receptor Activity Through Increased Oxidative Stress.
Pahwa R; Jialal I
Metab Syndr Relat Disord; 2016 Jun; 14(5):239-41. PubMed ID: 27105077
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
[TBL] [Abstract][Full Text] [Related]
14. [AGE receptor].
Matsumoto K; Sano H; Horiuchi S
Nihon Rinsho; 1997 Nov; 55 Suppl():867-71. PubMed ID: 9434579
[No Abstract] [Full Text] [Related]
15. Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease.
Bierhaus A; Ritz E; Nawroth PP
Nephrol Dial Transplant; 1996; 11 Suppl 5():87-90. PubMed ID: 9044315
[TBL] [Abstract][Full Text] [Related]
16. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.
Wautier MP; Chappey O; Corda S; Stern DM; Schmidt AM; Wautier JL
Am J Physiol Endocrinol Metab; 2001 May; 280(5):E685-94. PubMed ID: 11287350
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptors.
Vlassara H; Bucala R
Diabetes; 1996 Jul; 45 Suppl 3():S65-6. PubMed ID: 8674896
[TBL] [Abstract][Full Text] [Related]
18. Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication.
Yamagishi S; Nakamura K; Matsui T; Noda Y; Imaizumi T
Curr Pharm Des; 2008; 14(5):487-95. PubMed ID: 18289075
[TBL] [Abstract][Full Text] [Related]
19. What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose.
Yan SD; Stern D; Schmidt AM
Eur J Clin Invest; 1997 Mar; 27(3):179-81. PubMed ID: 9088851
[No Abstract] [Full Text] [Related]
20. AGE in micro- and macroangiopathy.
Lapolla A; Traldi P; Fedele D
Contrib Nephrol; 2001; (131):10-21. PubMed ID: 11125555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
